Related Experiment Video

Updated: Aug 7, 2026

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites
13:35

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites

Published on: March 1, 2018

Correlation between plasma and urinary caffeine levels in preterm infants

Luigi Cattarossi1, Marco Violino, Franco Macagno

  • 1Department of Pediatrics, Ospedale Civile di Tolmezzo, Italy. resppedto@ass3.sanita.fvg.it

Journal of Perinatal Medicine
|July 22, 2006
PubMed

Insights

Urine caffeine levels can reliably assess therapeutic drug ranges in preterm infants. This study found strong correlations between plasma and urine caffeine concentrations, supporting urine analysis as a practical monitoring method.

Area of Science:

  • Neonatal pharmacology
  • Clinical chemistry

Background:

  • Assessing therapeutic drug ranges is crucial for effective treatment.
  • Caffeine citrate is commonly used for apnea of prematurity in neonates.
  • Urine caffeine levels are hypothesized as a reliable biomarker.

Purpose of the Study:

  • To correlate plasma and urinary caffeine levels.
  • To evaluate urine caffeine levels for monitoring therapeutic ranges.
  • To investigate caffeine pharmacokinetics in preterm infants.

Main Methods:

  • A cohort of 56 preterm infants received caffeine citrate loading and maintenance doses.
  • Plasma and urine samples were collected at baseline and weekly intervals.
  • Statistical correlation analysis was performed on paired plasma and urine caffeine concentrations.

Main Results:

  • Strong positive correlations were observed between plasma and urinary caffeine levels across multiple postmenstrual ages (29-34 weeks).
  • Correlation coefficients (r) ranged from 0.81 to 0.97, all with P<0.001.
  • These findings indicate a consistent relationship between systemic and excreted caffeine.

Conclusions:

  • Urinary caffeine levels demonstrate potential as a non-invasive and practical method for assessing therapeutic drug ranges.
  • Monitoring urine caffeine may aid in optimizing caffeine citrate therapy for apnea of prematurity.
  • Further research can validate urine caffeine levels for routine clinical use.
Abstract

More Related Videos

Application of an Amplitude-integrated EEG Monitor (Cerebral Function Monitor) to Neonates05:58

Application of an Amplitude-integrated EEG Monitor (Cerebral Function Monitor) to Neonates

Published on: September 6, 2017

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo12:17

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

Published on: August 2, 2017

Related Concept Videos

Drug Concentration Versus Time Correlation01:15

Drug Concentration Versus Time Correlation

The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the lowest drug...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Concentrations: Measurements01:23

Drug Concentrations: Measurements

Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma —...